Drug profile · INN
oblimersen
GENASENSE
oblimersen (GENASENSE) is a bcl-2 mrna antisense inhibitor.
EMA: refused
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — oblimersen
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
oblimersen (GENASENSE) is a bcl-2 mrna antisense inhibitor.
Key facts
INN oblimersen
Brand GENASENSE
Mechanism Bcl-2 mRNA antisense inhibitor
Target Bcl-2 mRNA
Mechanism of action
Bcl-2 mRNA antisense inhibitor
Primary target: Bcl-2 mRNA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | refused | — |
Frequently asked questions
What is oblimersen?
oblimersen (GENASENSE) is a bcl-2 mrna antisense inhibitor.
What is the brand name for oblimersen?
GENASENSE is a marketed brand name for oblimersen. Check FDA Drugs@FDA for the current US label holder and prescribing information.